Skip to main content
NeuronFeed
Startups
Deals
News
Rankings
More
Neuron Verdicts
AI verdicts, ranked by score
Conferences
AI events & summits 2026/27
Categories
All verticals
Countries
AI activity by geography
Reviews
Hands-on verdicts
Compare
Side-by-side comparison
Alternatives
Switch from expensive SaaS
Intelligence
Market reports
Funding
Recent rounds
Investors
VCs + angels
Agent-Ready
MCP + API readiness
Tech Stack
Frameworks + infra
Market Maps
Competitive landscapes
86
upcoming events
⌘K
Sign in
+
Submit
Startup
Add a company to the AI directory
Investor
VC fund, angel, or accelerator
Person
Founder, exec, or researcher
Funding round
Share a recent raise
Conference
AI event, summit, or workshop
See all submission types →
Menu
Startups
Deals
News
Rankings
Neuron Verdicts
AI verdicts, ranked by score
Conferences
AI events & summits 2026/27
Categories
All verticals
Countries
AI activity by geography
Reviews
Hands-on verdicts
Compare
Side-by-side comparison
Alternatives
Switch from expensive SaaS
Intelligence
Market reports
Funding
Recent rounds
Investors
VCs + angels
Agent-Ready
MCP + API readiness
Tech Stack
Frameworks + infra
Market Maps
Competitive landscapes
+ Submit →
Sign in
Home
/
Funding
/
Superluminal Medicines Series A
Superluminal Medicines
· Series A
Amount
$120M
Round
Series A
Valuation
—
Announced
—
Search NeuronFeed
Esc
Home
Startups
News
Search
More
More
Neuron Verdicts
Conferences
Categories
Countries
Reviews
Compare
Alternatives
Intelligence
Funding
Investors
Agent-Ready
Tech
Market Maps
+ Submit →
Account / Sign in